Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 644-654 , April 2010

How Much Does It Cost a Specialist Palliative Care Unit to Manage Constipation in Patients Receiving Opioid Therapy?

  • Bee Wee, MB BCh, MRCGP, FRCP, MA Ed, PhD

      Affiliations

    • Sir Michael Sobell House, Churchill Hospital, Oxford, United Kingdom
    • Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom
    • Harris Manchester College, Oxford University, Oxford, United Kingdom
    • Corresponding Author InformationAddress correspondence to: Bee Wee, MB BCh, MRCGP, FRCP, MA Ed, PhD, Sir Michael Sobell House, Churchill Hospital, Oxford OX3 7LJ, United Kingdom.
    • ,
  • Astrid Adams, MBBS, BSc, Dip Pall Med, MRCP

      Affiliations

    • Sir Michael Sobell House, Churchill Hospital, Oxford, United Kingdom
    • Oxford Deanery, Oxford, United Kingdom
    • ,
  • Kate Thompson, BN, PgD Advanced Nursing, MSc

      Affiliations

    • Sir Michael Sobell House, Churchill Hospital, Oxford, United Kingdom
    • ,
  • Fran Percival, BPharm(Hons), MA, MRPharmS

      Affiliations

    • pH Associates, Marlow, United Kingdom
    • ,
  • Kate Burslem, BSc(Hons), MSc

      Affiliations

    • Wyeth Pharmaceuticals, Taplow, United Kingdom
    • ,
  • Minesh Jobanputra, MB ChB

      Affiliations

    • Wyeth Pharmaceuticals, Taplow, United Kingdom

,Accepted 28 September 2009.

  • Image Result

    Opioids on admission. IR: immediate-release tablets or liquid; SR: slow-release tablets; Codeine: any codeine-containing formulation, including compound preparations; SC: subcutaneous injection or inf

    Opioids on admission. IR: immediate-release tablets or liquid; SR: slow-release tablets; Codeine: any codeine-containing formulation, including compound preparations; SC: subcutaneous injection or infusion.

  • Image Result
    Laxatives prescribed on admission.

    Laxatives prescribed on admission.

  • Image Result
    Estimated distribution of total costs associated with the management of constipation.

    Estimated distribution of total costs associated with the management of constipation.

 This study was carried out with the financial support of Wyeth Pharmaceuticals in the form of payment for pH Associates, an independent research organization, to perform data collection and analysis; and an honorarium to the host organization and research group at Sir Michael Sobell House where this study was undertaken.

PII: S0885-3924(10)00080-1

doi: 10.1016/j.jpainsymman.2009.09.007

Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 644-654 , April 2010

Article Tools

* Image Usage & Resolution